SIDE-EFFECTS OF INTERMEDIATE-DOSE AND HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE-LEUKEMIA AND NON-HODGKINS-LYMPHOMA

This publication has 19 references indexed in Scilit:

• Palmar-Plantar Skin Changes and Cytarabine
  Annals of Internal Medicine, 1985
• Topical Corticosteroid Therapy for Corneal Toxicity from Systemically Administered Cytarabine
  American Journal of Ophthalmology, 1982
• A PILOT-STUDY OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE FOR ACUTE-LEUKEMIA AND REFRACTORY LYMPHOMA - CLINICAL-RESPONSE AND PHARMACOLOGY
  1982
• Selective Antimicrobial Modulation of Human Microbial Flora: Infection Prevention in Patients with Decreased Host Defense Mechanisms by Selective Elimination of Potentially Pathogenic Bacteria
  The Journal of Infectious Diseases, 1981
• Corneal Toxicity with Systemic Cytarabine
  American Journal of Ophthalmology, 1981
• Ara-C lung: Noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia
  The American Journal of Medicine, 1981
• PREVENTION OF PLATELET REFRACTORINESS DUE TO HLA ANTIBODIES BY ADMINISTRATION OF LEUKOCYTE-POOR BLOOD COMPONENTS
  1981
• Acute Leukemia: Biology and Treatment
  Annals of Internal Medicine, 1979
• High dose cytosine arabinoside (HDARAC) in refractory acute leukemia
  Cancer, 1979
• Advances in the Treatment of Acute Myelogenous Leukemia
  New England Journal of Medicine, 1979